THRio - PowerPoint PPT Presentation

1 / 40
About This Presentation
Title:

THRio

Description:

Death rates over time in our cohort. How many deaths are we missing? ... To better understand what's going on. Rates per 4-month periods from Jan '03-Mar '07 ... – PowerPoint PPT presentation

Number of Views:13
Avg rating:3.0/5.0
Slides: 41
Provided by: antoniogui
Category:
Tags: goingover | thrio

less

Transcript and Presenter's Notes

Title: THRio


1
THRio
  • Antonio G F Pacheco

2
THRio
  • Outline
  • Database setup
  • Creating a master table with main outcomes
  • Mortality recovery with linkage
  • Issues and differences between units

3
THRio
Database
4
THRio
  • We needed to evaluate the intervention
  • Intervention itself is training professionals and
    facilitate guidelines implementation
  • Request TST for eligible patients
  • Give IPT for eligible patients
  • First approach
  • Percentages
  • Given eligible patients for TST
  • Given eligible patients for IPT
  • There are problems with this approach

5
THRio
  • Issues
  • There is a lead time between training and
    following guidelines
  • Thats variable for each clinic
  • Frequency with which patients return to clinic
  • Logistic problems within the clinic
  • TST is not placed every day
  • To start IPT, TB has to be ruled out
  • It could take a long time to get a chest X-ray!!!

6
THRio
  • We thought we would have to take time into
    account!
  • Instead of percentages, rates
  • The process a patient goes through is pretty
    complex
  • There are dynamics issues involved
  • We tried to understand the dynamics first

7
THRio
  • Understanding the dynamics of patients
  • Patients may go through several states
  • Events of interest are all dated
  • It is possible to calculate transition rates
  • It would be useful for process analysis
  • Taking time into account
  • Lets see it schematically

8
Dynamics
9
THRio
  • Main table generated by the system
  • Based on the schematic part only
  • Takes info from several tables
  • Lots of programming involved
  • 9 SQL views
  • Delphi (Pascal) programming
  • gt 1000 lines of code
  • Computationally-intensive
  • About 40 min in a AMD 2 x 1.6 GHz with 2Gb RAM

10
THRio
  • Other outcomes included
  • TB outcomes
  • IPT outcomes
  • 20 different codes (with dates)
  • Long format database
  • Lets see an example with some fake data

11
THRio
  • Actually now it is easy to extend it
  • Implemented in Python
  • Mainly date functions
  • Could easily be extended in other languages (e.g.
    SAS)
  • Extra info from patients
  • HAART
  • CD4
  • VL
  • Extra info from study
  • Intervention status

12
THRio
  • Lets see one script

13
THRio
  • Now we can calculate rates
  • Can present data as a survival analysis
  • Compare pre- and post-intervention
  • Calendar x non-calendar analysis
  • Dynamics of the study
  • Dynamics of the intervention
  • Can be presented by clinic as well

14
THRio
15
THRio
16
THRio
17
THRio
Death Rates
18
THRio
  • Death rates over time in our cohort
  • How many deaths are we missing?
  • With linkage we are able to improve the numbers
  • But how much?
  • Is our death rate reasonable?
  • Are there differences over time?
  • Are there differences across units?

19
THRio
  • Patients known to be dead at data abstraction
  • Between Sep 03 and Sep 05
  • Abstracted as inactive
  • In the beginning not even after Sep 05
  • We started recovering them
  • Since Sep 03
  • No data abstracted if patients did not have a
    visit after Sep 03

20
THRio
  • Problem
  • These patients are not included in the analyses
  • Potential biases on results
  • Linkage with main database would fail
  • If we dont even have names or DOBs
  • Main biases
  • Outcomes unrelated with deaths
  • Outcomes associated with deaths
  • Death as an outcome

21
THRio
  • Overall death rates
  • From Sep 03-Aug 05
  • 1.95/100 pys
  • From Sep 05-Mar 07
  • 3.49/100 pys
  • The problem is there is no reason to believe the
    rates are increasing
  • If we are missing during the study, it is much
    worse before it began!
  • Lets see the rates per year

22
THRio
23
THRio
  • To better understand whats going on
  • Rates per 4-month periods from Jan 03-Mar 07
  • Number of deaths
  • Person-years contribution
  • There are at least 3 things to be explained

24
THRio
25
THRio
26
THRio
27
THRio
  • What about differences among units?
  • Lets try to see the issues of person-time and
    deaths per units
  • Starting with the person-years

28
THRio
29
THRio
  • The mean contribution is lower for half of the
    units
  • This is an operational issue of the way data is
    collected in this study
  • For the 10th and 11th periods, it doesnt seem
    that bad
  • For deaths, if we exclude the 1st, 2nd and last
    periods, we can compare the rates per unit

30
THRio
  • Lets see the death rates
  • Excluding the 1st, 2nd periods
  • Using 9th, 10th and 11th periods as the standard
    death rate
  • Rates and 95 CIs per unit
  • A little underestimated
  • Lets compare the death rates in the other
    periods per unit
  • How it is evolving over time
  • 6th and 7th periods problem

31
THRio
32
THRio
33
THRio
  • In fact some units caught up earlier
  • Majority did not
  • Even the ones that are within the CIs are
    consistently lower than the reference rate
  • 7 units have similar rates
  • Problem
  • Some units remove charts from archives soon after
    the patient is known to be dead
  • Lets look at those periods

34
THRio
35
THRio
  • Lets try to see all of them over time

36
THRio
37
THRio
  • So far, it looks a bad idea to use the time
    period before the study began to study mortality
  • What could be done to improve that?
  • Run linkage with inactive patients
  • We wouldnt have all the info
  • But could at least learn about vital status
  • Would help for Sep 03 to Dec 05

38
THRio
  • What about the mortality after the study began?
  • My guess is that we will have about 3.6/100 pys
  • Lets see where it comes from

39
THRio
40
THRio
  • Further steps
  • Compare that rate with rates in the literature
  • Stratify them by HAART use and CD4 counts
  • See if rates per stratum are reasonable
  • Also compare with other studies
Write a Comment
User Comments (0)
About PowerShow.com